Orange Book product · Generic (ANDA)
CLORAZEPATE DIPOTASSIUM
CLORAZEPATE DIPOTASSIUM
At a glance
Oct 26, 1987
Approved
Generic (ANDA)
Application
Not listed
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Oct 26, 1987
39 yr 3 mo ago
Today
Pharmaceutical detail
Active ingredient
CLORAZEPATE DIPOTASSIUM
Strength
7.5MG
Dosage form
TABLET
Route
ORAL
TE code
Not listed
Application
ANDA 071731
Product number
001
Marketing status
DISCN
Reference listed drug (RLD)
No
Reference standard (RS)
No
Active-ingredient family
View full familyGeneric (ANDA) of CLORAZEPATE DIPOTASSIUM
- —TRANXENEBrand (NDA)
NDA 017105 · AJENAT PHARMS
- 2022CLORAZEPATE DIPOTASSIUMGeneric (ANDA)
ANDA 213730 · NOVITIUM PHARMA
- 2022CLORAZEPATE DIPOTASSIUMGeneric (ANDA)
ANDA 215566 · COREPHARMA
- 1990CLORAZEPATE DIPOTASSIUMGeneric (ANDA)
ANDA 072514 · AUROLIFE PHARMA LLC
- 1988CLORAZEPATE DIPOTASSIUMGeneric (ANDA)
ANDA 071549 · QUANTUM PHARMICS
- 1988CLORAZEPATE DIPOTASSIUMGeneric (ANDA)
ANDA 071550 · QUANTUM PHARMICS
- 1988CLORAZEPATE DIPOTASSIUMGeneric (ANDA)
ANDA 071522 · QUANTUM PHARMICS
- 1988CLORAZEPATE DIPOTASSIUMGeneric (ANDA)
ANDA 072112 · RISING
- 1988CLORAZEPATE DIPOTASSIUMGeneric (ANDA)
ANDA 072330 · PUREPAC PHARM
- 1988CLORAZEPATE DIPOTASSIUMGeneric (ANDA)
ANDA 072331 · PUREPAC PHARM
- 1988CLORAZEPATE DIPOTASSIUMGeneric (ANDA)
ANDA 072332 · PUREPAC PHARM
- 1988CLORAZEPATE DIPOTASSIUMGeneric (ANDA)
ANDA 071924 · PUREPAC PHARM
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.

